Pharma Pulse 7/11/24: Gender and Racial Disparities in Youth Psychiatric Inpatient Admissions, Microsoft Quits OpenAI’s Board & more

Leveraging eCOA Technologies to Create Greater Patient Centricity

In part 3 of this video interview, Kristy Birchard, product owner, patient engagement, YPrime touches on the importance of utilizing patient-reported outcomes.

Study Finds Gender and Racial Disparities in Youth Psychiatric Inpatient Admissions

The authors emphasize that these findings suggest a need for targeted resources that help reduce boarding and promote equitable access to care.

Microsoft Quits OpenAI’s Board Amid Antitrust Scrutiny

Role of observer was part of a tie-up that is facing scrutiny in the U.S. and Europe.

Thermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period

Thermo Fisher Scientific Inc. announced that it has completed its acquisition of Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), a leading provider of next-generation proteomics solutions. The transaction values Olink at approximately $3.1 billion, net of $96 million of acquired cash. Olink will become part of Thermo Fisher's Life Sciences Solutions segment.

PharmExec on LinkedIn

The countdown begins! There's only one week left to showcase your groundbreaking work at the 2024 Pharmaceutical Executive® APEX Awards. Whether you're advancing patient care or leading innovative therapies, your contributions deserve recognition.

Don't miss this opportunity to join industry leaders on November 14th in NYC. Submit your entries today and be part of this prestigious event!

Enter now: https://ow.ly/jxKL50SuUrI

#PharmaMarketing #HealthcareInnovation #PEAPEXAwards

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs